Trump-touted hydroxychloroquine shows no benefit in COVID-19 prevention: study
(Reuters) - A malaria drug taken by U.S. President Donald Trump to prevent COVID-19 did not show any benefit versus placebo in reducing coronavirus infection among healthcare workers, according to clinical trial results published on Wednesday. CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and earn CLick here and ea